Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system that commonly causes optic neuritis. While people with MS can initially recover from optic neuritis, over ...

Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG ...

Outcomes in acute optic neuritis tend to be worse at 6 months for men, patients who are older and those with poorer ...

The company will use the funds for the global introduction of its robotic retinal imaging, AI and teleophthalmology platform.

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...

“The retina is the most accessible part of the central nervous system…OCT allows us to quantify each of these neuronal and axonal layers as they are organized within the retina. And the reason we have ...

Eye exams are an essential tool for detecting diseases such as diabetic retinopathy, glaucoma, and age-related macular ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic nerve in a phase 2 study. The ACUITY trial in France analyzed 33 patients who ...

ZUG, Switzerland, January 6, 2025 – Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced ...